RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
  TestosteroneReplacement Therapy
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Men's Health Channel

subscribe to Men's Health newsletter
Health : Men's Health

   EMAIL   |   PRINT
Genetic clues to male baldness found

Oct 16, 2008 - 11:53:59 AM
Hair transplantation in the US alone cost $115 million in 2007, and therapy for male-pattern baldness globally generates many times more revenue.

 
[RxPG] Toronto, Oct 16 - Researchers have found two DNA variants in Caucasian men that could be linked to higher risk of male pattern baldness.


Male pattern baldness is the most common form of baldness which leads to loss of hair in a well-defined pattern, beginning with the temples and resulting in a distinctive M-shaped hairline.

But the new findings may lead to an early prediction about hair loss and a future treatment to check male pattern baldness which affects one in three males over the age of 45.

As part of their research, medical scientists from McGill University in Montreal, GlaxoSmithKline -, and King's College in London conducted a genome-wide association study of 1,125 Caucasian men who had been assessed for male pattern baldness, a McGill university release said.

They found two previously unknown genetic variants on chromosome 20 - that substantially increased the risk of male pattern baldness.

To confirm these findings, they carried out further research on additional 1,650 Caucasian men.

'I would presume male pattern baldness is caused by the same genetic variation in non-Caucasians,' said Brent Richards, an assistant professor in genetic epidemiology at McGill University.

'But we haven't studied those populations, so we can't say for certain,' he said, cautioning that the breakthrough does not mean a treatment or cure for male pattern baldness is imminent.

'We've only identified a cause,' Richards said.

'Treating male pattern baldness will require more research. But, of course, the first step in finding a way to treat most conditions it is to first identify the cause,' he said.

'Early prediction before hair loss starts may lead to some interesting therapies that are more effective than treating late stage hair loss,' added Tim Spector of King's College, London.

Researchers have long been aware of a genetic variant on the X chromosome that was linked to male pattern baldness, said Richards.

'That's where the idea that baldness is inherited from the mother's side of the family comes from,' he explained.

'However it's been long recognised that there must be several genes causing male pattern baldness. Until now, no one could identify those other genes. If you have both the risk variants we discovered on chromosome 20 and the unrelated known variant on the X chromosome, your risk of becoming bald increases sevenfold,' said Richards.

'What's startling is that one in seven men has both of those risk variants. That's 14 percent of the total population.'

It is estimated that about a third of all men are affected by male pattern baldness by age 45, taking a huge economic and social toll.

Hair transplantation in the US alone cost $115 million in 2007, and therapy for male-pattern baldness globally generates many times more revenue.

The findings have been published in the journal Nature Genetics.





Advertise in this space for $10 per month. Contact us today.


Related Men's Health News
New male infertility test could 'bring hope to millions'
Sleep loss can cause testosterone levels to plummet
Genetic clues to male baldness found
Venous embolization can help improve sperm function
New, noninvasive prostate cancer test beats PSA in detecting prostate cancer
Prostitution Defines AIDS Pandemic More Than Other Factors
CBT Workshop Effective for Insomnia in Males
Aging Process Reversed by Exercise
Now, a contraceptive pill for men
Testosterone Replacement Therapy Appears Safe For Prostate

Subscribe to Men's Health Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)